et al.
About
In The Last Decade
et al.
20 papers receiving 228 citations
Peers
Comparison fields: 5 of 103
- Atomic and Molecular Physics, and Optics 58
- Inorganic Chemistry 50
- Nuclear and High Energy Physics 47
- Sociology and Political Science 45
- General Decision Sciences 28
Countries citing papers authored by et al.
This map shows the geographic impact of et al.'s research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by et al. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites et al. more than expected).
Fields of papers citing papers by et al.
This network shows the impact of papers produced by et al.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by et al.. The network helps show where et al. may publish in the future.
Co-authorship network of co-authors of et al.
This figure shows the co-authorship network connecting the top 25 collaborators of et al.. A scholar is included among the top collaborators of et al. based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with et al.. et al. is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 0 | |
| 9 | Association between assisted reproductive technology and advanced retinopathy of prematurity | 1 |
| 10 | 91 | |
| 11 | Validation of reported physical activity for cholesterol control using two different physical activity instruments | 3 |
| 12 | Rituximab: An emerging therapeutic agent for kidney transplantation | 2 |
| 13 | 15 | |
| 14 | The osteoporotic male: Overlooked and undermanaged? | 6 |
| 15 | 1 | |
| 16 | 4 | |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 10 | |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.